Hye-Suk Han

Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer

Min‐Hee Ryu, Changhoon Yoo, Jong Gwang Kim et al. · European Journal of Cancer · 2015 · 129 citations

Oncology, Gastrointestinal Oncology, Advanced Gastric Cancer +6

Weight changes after adjuvant treatment in Korean women with early breast cancer

Hye-Suk Han, Keun‐Wook Lee, Jee Hyun Kim et al. · Breast Cancer Research and Treatment · 2008 · 51 citations

Obesity, Surgical Oncology, Korean Women +8

HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer

Ji‐Won Kim, Jee Hyun Kim, Seock‐Ah Im et al. · Cancer Chemotherapy and Pharmacology · 2013 · 27 citations

Breast Oncology, Taxane Chemotherapy, Her2 Fluorescence +7

Evaluation of Urine Cytology in Urothelial Carcinoma Patients: A Comparison of CellprepPlus® Liquid-Based Cytology and Conventional Smear

Seung-Myoung Son, Ji Hae Koo, Song‐Yi Choi et al. · The Korean Journal of Pathology · 2012 · 27 citations · Full text

Renal Pathology, Pathology, Oncology +16

Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy

Hye-Suk Han, Jin-Soo Kim, Jin Hyun Park et al. · Journal of Korean Medical Science · 2009 · 27 citations · Full text